Alnylam Pharmaceuticals | Zysk Brutto



Pre Tax Profit Zmiana Data
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 1.57B 405M 2025-06
Arrowhead Research USD -179089000 548.7M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 133M 2025-06
PTC Therapeutics USD -71052000 1B 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Sanofi USD 1.47B 855.43M 2025-06
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Takeda JPY 150.63B 257.93B 2025-06
Tectonic Therapeutic USD -19010000 1.29M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06
Xencor USD -31075000 17.19M 2025-06


Alnylam Pharmaceuticals Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.